Abstract

Impairment of glutamate neurons that relay sensory and cognitive information from the medial dorsal thalamus to the dorsolateral prefrontal cortex and other cortical regions may contribute to the pathophysiology of schizophrenia. In this study, we have assessed the cell-specific expression of glutamatergic transcripts in the medial dorsal thalamus. We used laser capture microdissection to harvest two populations of medial dorsal thalamic cells, one enriched with glutamatergic relay neurons and the other with gamma-aminobutyric acidergic neurons and astroglia, from postmortem brains of subjects with schizophrenia (n = 14) and a comparison group (n = 20). Quantitative polymerase chain reaction of extracted RNA was used to assay gene expression in the different cell populations. The transcripts encoding the ionotropic glutamate receptor subunits NR2D, GluR3, GluR6, GluR7, and the intracellular proteins GRIP1 and SynGAP1 were significantly decreased in relay neurons but not in the mixed glial and interneuron population in schizophrenia. Our data suggest that reduced ionotropic glutamatergic expression occurs selectively in neurons, which give rise to the cortical projections of the medial dorsal thalamus in schizophrenia, rather than in thalamic cells that function locally. Our findings indicate that glutamatergic innervation is dysfunctional in the circuitry between the medial dorsal thalamus and cortex.

Highlights

  • Schizophrenia is a debilitating psychiatric disorder which occurs in approximately 1% of the population worldwide

  • Our findings indicate that glutamatergic innervation is dysfunctional in the circuitry between the medial dorsal thalamus and cortex

  • This study demonstrates that reduced glutamatergic gene expression occurs in the relay neurons of the medial dorsal thalamus in schizophrenia

Read more

Summary

Introduction

Schizophrenia is a debilitating psychiatric disorder which occurs in approximately 1% of the population worldwide. Its etiology is not known, but with accumulating data, the glutamate hypothesis of schizophrenia has gained credibility [1,2,3,4,5] This hypothesis proposes that dysregulation within the glutamate neurotransmitter system contributes to the pathophysiology of schizophrenia, and arose from observations that some drugs blocking glutamatergic receptors can produce a psychosis more closely resembling schizophrenia than psychotomimetic drugs acting on other neurotransmitter systems[6,7,8]. These drugs can exacerbate symptoms experienced by schizophrenia patients[9]. In this study we have assessed the cellspecific expression of glutamatergic transcripts in the medial dorsal thalamus

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call